MOORESTOWN, N.J., April 23, 2018 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to optimize medication safety, will release its first quarter 2018 operating results on Tuesday, May 8, 2018 after market close, on the investor relations section of TRHC’s website at ir.trhc.com with a conference call hosted by Chairman and CEO, Calvin Knowlton, Ph.D., President, Orsula Knowlton, PharmD, MBA, and Chief Financial Officer, Brian Adams to follow at 5:00 p.m. EDT.
Stockholders and interested participants may listen to a live broadcast of the conference call by dialing 844-413-0947 or 216-562-0423 for international callers, and referencing participant code 1578756 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of TRHC’s website (ir.trhc.com) and an audio file of the call will also be archived and available for replay approximately two hours after the live event for a period of 90 days thereafter at ir.trhc.com. After the conference call, a replay will be available until May 15, 2018 and can be accessed by dialing 855-859-2056 or 404-537-3406 for international callers, and referencing participant code 1578756.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit: www.TRHC.com.
Contact:
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]
Media
Dianne Semingson
[email protected]
215-870-0829


Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 



